Cerebrovascular Diseases

Papers
(The H4-Index of Cerebrovascular Diseases is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Factors Associated with Discharge against Medical Advice among Acute Stroke Patients: Analysis of the Nationwide Emergency Department Sample38
Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease26
Retraction Statement24
Normobaric Hyperoxia Combined with Endovascular Treatment in Patients with Acute Ischemic Stroke (OPENS-2) Trial: Protocol for a Prospective, Multicenter, Randomized Controlled Study23
Circadian Rhythm Disturbance in Acute Ischemic Stroke Patients and Its Effect on Prognosis22
Rising Trends in Cerebrovascular Disease and Substance Use-Related Mortality in the USA from 1999 to 2020: A Retrospective Analysis Using CDC WONDER17
Reply to the Letter to the Editor: Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease – Impact of17
Intensive Blood Pressure Lowering and Renal Function in Ischemic Stroke Patients: Secondary Analysis of the ENCHANTED Trial16
A Global Health Perspective on the 2026 AHA/ASA Stroke Guidelines: Lessons from the Indian Health System15
Asia Pacific Stroke Conference 2024 Combined Australian and New Zealand Stroke Organisation Conference15
9th World Intracranial Hemorrhage Conference (WICH) 2025, Wesley Conference Centre, Sydney, Australia, March 28-29, 2025: Abstracts14
Development and Validation of a Prediction Model for 30-Day Mortality and Functional Outcome in Patients with Primary Brainstem Hemorrhage14
Variation in Ischemic Stroke Payments in the USA: A Medicare Beneficiary Study12
Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes with Alteplase at 0.6 mg/kg in Clinical Practice: THAWS2 Study12
0.18950486183167